52.13MMarket Cap-6.00P/E (TTM)
3.220High2.770Low72.13KVolume2.780Open3.420Pre Close208.94KTurnover0.57%Turnover RatioLossP/E (Static)16.39MShares9.00052wk High0.77P/B40.52MFloat Cap2.54052wk Low--Dividend TTM12.74MShs Float51.810Historical High--Div YieldTTM13.16%Amplitude2.540Historical Low2.896Avg Price1Lot Size
SHL Telemedicine Stock Forum
NEWS
SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test
SHL Telemedicine has unveiled a revolutionary at-home Biomarker blood test in Israel, enhancing their suite of telemedicine solutions. This test, guided by SHL’s medical team, follows a 12-lead ECG and aims to rapidly identify cardiac markers indicative of a heart attack. Results are available within ten minutes. SHL integrates this new test with anamnesis and ECG broad...
NEWS
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care
SHL Telemedicine announces groundbreaking results from the Imperial College London TELE-ACS Trial, showing a 76% decrease in hospital readmissions and a 41% decrease in Emergency Department visits for post-MI patients. The trial demonstrated the effectiveness of SHL's SmartHeart® technology in remote cardiac care, with significant reduction...
NEWS
SHL's SmartHeart portable 12-lead ECG technology successfully participated in the U.S. Army's Project Convergence - Capstone 4 experiment, showcasing exceptional reliability and user-friendliness. The technology demonstrated effectiveness in extreme scenarios, revolutionizing urgent cardiovascular assessment in non-traditional settings.
No comment yet